Nonstented versus routine stented ureteroscopic holmium laser lithotripsy: a prospective randomized trial.
We conducted a prospective, randomized study to evaluate whether postoperative ureteral stenting is necessary after ureteroscopic holmium laser lithotripsy. A total of 115 consecutive patients with distal or middle ureteral calculi amenable to ureteroscopic holmium laser lithotripsy were prospectively randomized into stented group (n = 58) and nonstented group (n = 57). The stent was routinely placed in the treated ureter for 2 weeks. The outcomes were measured with postoperative patient symptoms, stone-free rates, early and late postoperative complications, and cost-effectiveness. The postoperative symptoms were measured with Ureteral Stent Symptom Questionnaire (USSQ). All patients completed a 12-week follow-up. There was no significant difference between two groups with respect to the patient age, stone size, stone location and mean operative time. According to the USSQ, the symptoms of the stented group were significantly worse compared to the nonstented group (P = 0.0001). In the stented group, two patients had high fever for 1 week after the operation, stent migration was found in two patients, and the stents had to be removed earlier in five patients because of severe pain or hematuria. The cost of the stented group was significantly higher than the nonstented group. The stone-free rate was 100% in both groups. No hydronephrosis or ureteral stricture was detected by intravenous pyelogram in the 12th week postoperative follow-up. In conclusion, we believe that routine stenting after ureteroscopic intracorporeal lithotripsy with the holmium laser is not necessary as long as the procedure is uncomplicated for distal or middle ureteral calculis less than 2 cm.
Shao
Yi
Y
Department of Urology, Shanghai Jiaotong University Affiliated First People's Hospital, No 85, Wujin road, 200080, Shanghai, China.
Zhuo
Jian
J
Sun
Xiao-Wen
XW
Wen
Wei
W
Liu
Hai-Tao
HT
Xia
Shu-Jie
SJ
D000328:Adult; D005260:Female; D006695:Holmium; D006801:Humans; D017602:Lithotripsy, Laser; D008297:Male; D008875:Middle Aged; D011182:Postoperative Care; D011446:Prospective Studies; D015607:Stents; D014514:Ureteral Calculi / Q000628:therapy*; D014517:Ureteral Obstruction / Q000628:therapy
D006695:Holmium
J Urol. 1994 May;151(5):1185-7
8158756
Eur Urol. 2007 Sep;52(3):836-41
17258387
J Endourol. 1994 Oct;8(5):341-3
7858619
J Urol. 1998 Mar;159(3):723-6
9474134
J Urol. 1998 Jan;159(1):17-23
9400428
J Urol. 1991 Oct;146(4):966-9
1895452
J Urol. 1999 Jan;161(1):48-50
10037365
BJU Int. 2000 Mar;85(4):408-11
10691815
Eur Urol. 2004 Sep;46(3):381-7; discussion 387-8
15306112
World J Urol. 2006 Dec;24(6):681-3
17094007
Br J Urol. 1994 Oct;74(4):434-9
7820419
Eur Urol. 2000 Jul;38(1):41-4
10859440
J Urol. 2003 Apr;169(4):1257-60
12629338
Eur Urol. 1997;31(1):24-9
9032530
J Urol. 2001 Nov;166(5):1651-7
11586195
Urology. 1999 Jan;53(1):25-31
9886583
J Urol. 1997 Jan;157(1):28-32
8976208
J Urol. 2001 May;165(5):1419-22
11342889
Curr Opin Urol. 2006 Mar;16(2):77-82
16479208
J Urol. 2003 Mar;169(3):1065-9; discussion 1069
12576847
J Urol. 1997 Jun;157(6):2081-3
9146584